FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma.

Abstract

Oral squamous cell carcinoma (OSCC) is one of the most common malignancies of the head and neck. In OSCC patients, the prognosis was dramatically different. In this research, we aimed to study the expressions and prognostic values of IgG Fc binding protein (FCGBP) in OSCC patients. The expression of FCGBP was analyzed using TCGA datasets and GEO datasets. FCGBP was evaluated for its predictive significance in OSCC patients by the use of a Kaplan-Meier and Cox regression model. Enrichment analysis for the GO and KEGG databases were conducted. CIBERSORT used TCGA datasets to show immune cell infiltration. In addition, researchers looked into the relationships between FCGBP and immune cells. The levels of FCGBP in OSCC cells was examined through the use of RT-PCR. FCGBP overexpression was tested for its effects on OSCC cell proliferation and invasion using CCK-8 and Transwell assays. We observed that FCGBP expressions were distinctly downregulated in OSCC specimens compared with nontumor tissues in both TCGA and GEO datasets, which was further confirmed by RT-PCR. OSCC patients with advanced clinical stages and poor prognoses had lower levels of FCGBP expression. Many immune-related biological activities and signaling pathways were found to be considerably abundant in KEGG tests and GO analysis results. The correlation analysis indicated that FCGBP was associated with a number of immune cells in a positive way. We found that FCGBP expressions were strongly and distinctly linked to the expressions of known immunological checkpoints, and FCGBP expression had significant positive connections with tumor mutational burden. FCGBP upregulation distinctly slowed the growth and invasion of OSCC cells in functional experiments. FCGBP has the potential to be a therapeutic target for OSCC and a biomarker for OSCC patients' prognosis.

• Authors: Ting Shen, Jianying Zhang, Yali Wang, Binjie Liu
• Journal: Journal of immunology research (J Immunol Res) Vol. 2022 Pg. 8443392 ( 2022) ISSN: 2314-7156 [Electronic] Egypt
• PMID: 35733916 (Publication Type: Journal Article)
• Copyright: Copyright © 2022 Ting Shen et al.

Chemical References

• Carrier Proteins
• Cell Adhesion Molecules
• FCGBP protein, human

Topics

• Carrier Proteins (metabolism)
• Cell Adhesion Molecules (metabolism)
• Gene Expression Regulation, Neoplastic
• Humans
• Immunotherapy
• Mouth Neoplasms (genetics, therapy)
• Prognosis
• Squamous Cell Carcinoma of Head and Neck (genetics, therapy)